Back to Search
Start Over
Key issues in inhibitor management in patients with haemophilia.
- Source :
-
Blood transfusion = Trasfusione del sangue [Blood Transfus] 2014 Jan; Vol. 12 Suppl 1, pp. s319-29. Date of Electronic Publication: 2013 Dec 03. - Publication Year :
- 2014
- Subjects :
- Blood Coagulation Factors therapeutic use
Disease Management
Dose-Response Relationship, Immunologic
Factor IX genetics
Factor IX therapeutic use
Factor VIII genetics
Factor VIII therapeutic use
Factor VIIa therapeutic use
Genetic Predisposition to Disease
Hemophilia A genetics
Hemophilia A therapy
Hemophilia B genetics
Hemophilia B therapy
Humans
Immunization
Immunosuppression Therapy methods
Multicenter Studies as Topic
Mutation, Missense
Phenotype
Primary Prevention
Prospective Studies
Randomized Controlled Trials as Topic
Recombinant Proteins immunology
Recombinant Proteins therapeutic use
Risk Factors
Factor IX immunology
Factor VIII immunology
Hemophilia A immunology
Hemophilia B immunology
Isoantibodies immunology
Subjects
Details
- Language :
- English
- ISSN :
- 2385-2070
- Volume :
- 12 Suppl 1
- Database :
- MEDLINE
- Journal :
- Blood transfusion = Trasfusione del sangue
- Publication Type :
- Academic Journal
- Accession number :
- 24333092
- Full Text :
- https://doi.org/10.2450/2013.0246-12